Report: Medicare Pays Too Much for Some New Generics

Posted by Jacob Goldstein in WSJ Health Blog When a drug goes generic, the price plunges. But the formula Medicare uses to pay for certain drugs is slow to reflect that price drop, which means the program winds up overpaying for months. Read all about it in this report out today from Health and Human Services’ inspector general.